- Report
- June 2025
- 150 Pages
Global
From €2393EUR$2,699USD£2,085GBP
- Report
- June 2025
- 150 Pages
Global
From €2393EUR$2,699USD£2,085GBP
- Report
- May 2025
- 300 Pages
Global
From €4389EUR$4,949USD£3,823GBP
- Report
- October 2025
- 144 Pages
Global
From €3546EUR$3,999USD£3,090GBP
- Report
- March 2026
- 149 Pages
Global
From €3546EUR$3,999USD£3,090GBP
- Report
- November 2025
- 150 Pages
Global
From €3325EUR$3,750USD£2,897GBP
- Report
- January 2026
- 286 Pages
Global
From €2217EUR$2,500USD£1,931GBP
- Report
- June 2025
- 400 Pages
Global
From €4389EUR$4,949USD£3,823GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2473EUR$2,789USD£2,155GBP
- Report
- August 2025
- 260 Pages
Global
From €4429EUR$4,995USD£3,859GBP
- Report
- January 2026
- 128 Pages
Global
From €3503EUR$3,950USD£3,052GBP
- Report
- June 2025
- 138 Pages
Global
From €3503EUR$3,950USD£3,052GBP
- Report
- February 2026
- 160 Pages
Global
From €2944EUR$3,320USD£2,565GBP
€3680EUR$4,150USD£3,206GBP
- Report
- January 2026
- 160 Pages
Global
From €2978EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- January 2026
- 160 Pages
Global
From €2978EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- November 2025
- 160 Pages
Global
From €2977EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- November 2025
- 160 Pages
Global
From €2977EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- October 2025
- 160 Pages
Global
From €2977EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- October 2025
- 160 Pages
Global
From €2977EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP
- Report
- August 2025
- 150 Pages
Global
From €2977EUR$3,358USD£2,594GBP
€3503EUR$3,950USD£3,052GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more